Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2025-12-25 @ 2:02 AM
NCT ID:
NCT06159660
Eligibility Criteria:
Inclusion Criteria:
* Aged 18 years or older.
* Eastern Cooperative Oncology Group (ECOG) performance status 0-2.
* Histologically proven Stage II-IV non-small cell lung cancer as determined using the IASLC International Association for the Study of Lung Cancer (IASLC) 8th edition lung cancer staging guidelines.
* To be treated with curative intent (stage II-III) or palliative intent (stage IV) with non-SABR external beam radiotherapy (e.g. 60 Gy in 30 treatments for curative intent or 30 Gy in 5 treatments for palliative intent).
* Pulmonary function tests within 8 weeks of registration.
* 4DCT simulation for radiation therapy.
* Willingness to give written informed consent.
* Willingness and ability to comply with the study procedures and visit requirements.
* Available for follow up for 1 year or until death, whichever occurs first.
Exclusion Criteria:
* Prior radiation therapy to the thorax.
* Prior surgery for this cancer.
* Prior chemotherapy for this cancer.
* Interstitial lung disease.
* Pregnant women.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06159660
Study Brief:
Protocol Section:
NCT06159660